9.53
前日終値:
$9.99
開ける:
$9.95
24時間の取引高:
962.76K
Relative Volume:
1.16
時価総額:
$915.93M
収益:
-
当期純損益:
-
株価収益率:
-16.91
EPS:
-0.5635
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.11%
1か月 パフォーマンス:
-21.82%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
Lumexa Imaging Holdings Inc Stock (LMRI) Company Profile
名前
Lumexa Imaging Holdings Inc
セクター
電話
704-334-7830
住所
4200 SIX FORKS ROAD, RALEIGH
Compare LMRI vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
LMRI
Lumexa Imaging Holdings Inc
|
9.53 | 960.14M | 0 | 0 | 0 | -0.5635 |
|
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lumexa Imaging Holdings Inc Stock (LMRI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-09 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2026-01-05 | 開始されました | Barclays | Overweight |
| 2026-01-05 | 開始されました | Deutsche Bank | Buy |
| 2026-01-05 | 開始されました | JP Morgan | Overweight |
| 2026-01-05 | 開始されました | Jefferies | Buy |
| 2026-01-05 | 開始されました | Leerink Partners | Outperform |
| 2026-01-05 | 開始されました | Raymond James | Outperform |
| 2026-01-05 | 開始されました | Wells Fargo | Overweight |
| 2026-01-05 | 開始されました | William Blair | Outperform |
すべてを表示
Lumexa Imaging Holdings Inc (LMRI) 最新ニュース
Top Lumexa Imaging (LMRI) Competitors 2026 - MarketBeat
Jefferies reiterates Lumexa Imaging stock rating on demand outlook By Investing.com - Investing.com Canada
LMRI Maintains Overweight by Barclays -- Price Target Lowered to $15.00 - GuruFocus
Lumexa Imaging price target lowered to $15 from $23 at Barclays - TipRanks
Analysts’ Top Technology Picks: IonQ (IONQ), Lumexa Imaging Holdings, Inc. (LMRI) - The Globe and Mail
Lumexa Imaging reiterates 2026 guidance during site visit By Investing.com - Investing.com Australia
Lumexa Imaging reiterates 2026 guidance during site visit - Investing.com
Lumexa Imaging Holdings IncReiterates full year 2026 guidance on April 8, 2026SEC filing - marketscreener.com
Lumexa Imaging Reaffirms Full-Year 2026 Financial Guidance - TipRanks
Lumexa Imaging reiterates full-year 2026 guidance after site visit - TradingView — Track All Markets
Lumexa Imaging (LMRI) reiterates previously disclosed full-year 2026 guidance - Stock Titan
Should I buy Lumexa Imaging Holdings, Inc. (LMRI) - Zacks Investment Research
Lumexa Imaging Holdings, Inc. Common Stock Stock Forecast Summary - Meyka
Lumexa Imaging Earnings Call Highlights Growth Momentum - TipRanks
Earnings Call Summary | Lumexa Imaging(LMRI.US) Q4 2025 Earnings Conference - 富途牛牛
Maintaining Buy on LMRI: Market Overdiscounts Consolidated Centers, Creating Upside to $17 Target - TipRanks
Raymond James cuts Lumexa Imaging stock price target on soft outlook - Investing.com Canada
Lumexa Imaging price target lowered to $17 from $23 at Raymond James - TipRanks
Jefferies reiterates Lumexa Imaging stock rating citing growth outlook By Investing.com - Investing.com Canada
LMRI SEC FilingsLumexa Imaging Holdings 10-K, 10-Q, 8-K Forms - Stock Titan
Lumexa Imaging (NASDAQ: LMRI) hits $1.023B revenue and raises $427M IPO - Stock Titan
Lumexa Imaging: Clearer Growth Path Ahead (NASDAQ:LMRI) - Seeking Alpha
LMRI Technical Analysis & Stock Price Forecast - Intellectia AI
Analysts Offer Insights on Technology Companies: Intuit (INTU), Rubrik, Inc. Class A (RBRK) and Lumexa Imaging Holdings, Inc. (LMRI) - theglobeandmail.com
Analysts Offer Insights on Technology Companies: Lumexa Imaging Holdings, Inc. (LMRI), Adobe (ADBE) and Blaize Holdings (BZAI) - The Globe and Mail
Lumexa Imaging Reports Strong Q4 and Full Year 2025 Results, Reiterates 2026 Guidance and Outlines Growth Strategy - Minichart
Lumexa Imaging Posts Strong Q4 Growth, Reaffirms 2026 Outlook - TipRanks
Lumexa Imaging Holdings, Inc. Shareholders Are Encouraged - GlobeNewswire
Lumexa Imaging Holdings, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewswire Inc.
Earnings call transcript: Lumexa Imaging Q4 2025 reveals unexpected EPS miss - Investing.com Canada
Leerink reiterates Outperform on Lumexa Imaging stock at $23 By Investing.com - Investing.com Canada
Leerink reiterates Outperform on Lumexa Imaging stock at $23 - Investing.com
Lumexa Imaging Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance - Bitget
Lumexa Imaging Holdings Inc has released its financial guidance for 2026, expecting adjusted EBITDA to be between $234 million and $242 million. - Bitget
Lumexa Imaging Q4 Loss Widens, Revenue Rises; Issues 2026 Adjusted EPS Guidance - MarketScreener
Lumexa: Q4 Earnings Snapshot - MarketScreener
Lumexa Imaging (Nasdaq: LMRI) grows 2025 revenue, cuts debt and loss - Stock Titan
Earnings Flash (LMRI) Lumexa Imaging Posts Preliminary Q4 Loss $0.38 a Share - marketscreener.com
Earnings Flash (LMRI) Lumexa Imaging Holdings, Inc. Reports Q4 Revenue $267.7M, vs. FactSet Est of $261.2M - MarketScreener
Lumexa says new imaging centers and scan demand lifted EBITDA 19% - Stock Titan
Raymond James reiterates Strong Buy on Lumexa Imaging stock - Investing.com UK
Raymond James reiterates Strong Buy on Lumexa Imaging stock By Investing.com - Investing.com India
Raymond James says helium concerns behind Radnet stock sell-off overblown - Investing.com Canada
Raymond James says helium concerns behind Radnet stock sell-off overblown By Investing.com - za.investing.com
Lumexa Imaging Holdings Inc (LMRI) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):